Seoul:South Korean biosimilar company Samsung Epis Holdings reported a net profit of 96.3 billion won (US$71.9 million) for the third quarter.
According to Yonhap News Agency, the company, which is part of the Samsung Group, disclosed in a regulatory filing that its operating profit for the July-September period was 105.1 billion won.
Revenue for the biotech company during this quarter amounted to 441.9 billion won.